Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

64-73-3

Demeclocycline HCl

64-73-3
936-05-0

Dimetridazole hydroxy

936-05-0
15307-86-5

Diclofenac

15307-86-5
25316-40-9

Doxorubicine HCl

25316-40-9
700367-34-6

Docetaxel H2O

700367-34-6
23541-50-6

Daunorubicine HCl

23541-50-6
84-17-3

Dienestrol

84-17-3
562-10-7

Doxylamine

562-10-7
5907-38-0

Dipyron H2O

5907-38-0
6898-97-1

Diethylstilbestrol

6898-97-1
130606-60-9

Diltiazem N-Desmethyl HCl

130606-60-9
111-96-6

Diglyme

111-96-6
24390-14-5

Doxycycline hyclate

24390-14-5
3219-99-6

Doxycycline 6-epi

3219-99-6
7081-53-0

Doxapram HCl H2O

7081-53-0
145-41-5

Dehydrocholate sodium

145-41-5
302-95-4

Desoxycholate sodium

302-95-4
201530-41-8

Deferasirox

201530-41-8
50-02-2

Dexamethason

50-02-2
141625-93-6

Dronedaron HCl

141625-93-6